Filamentous Actin in the Role of Diagnosing Seronegative Type 1 Autoimmune Hepatitis by Hall, Mallory et al.
Filamentous Actin In The Role of 
Diagnosing Seronegative Type 1 
Autoimmune Hepatitis
Mallory Hall, DO; Addison McGinn, MD; Kevin Smith, DO
Department of Internal Medicine at 
OU School of Community Medicine, Tulsa, OK
Introduction
• Autoimmune Hepatitis (AIH) is an inflammatory liver disease 
which, without timely diagnosis and treatment, can progress 
to cirrhosis. 
• There are no distinguishing clinical features to discriminate 
this from other liver pathology
• Diagnosis is made by the presence of circulating 
autoantibodies, elevated serum globulin levels, and 
histologic examination. 
Case Presentation
• 65-year-old female with no significant PMH who presented with 
non-specific abdominal complaints subsequently found to have 
unexplained liver cirrhosis
Case Description
• Pertinent negatives: No evidence of past or present alcohol 
abuse. Viral hepatitis panel nonreactive. HFE gene were negative. 
Autoantibodies including antinuclear, liver/kidney microsomal, 
soluble liver antigen, and anti-microsomal were nonreactive. 
• Pertinent positives: IgG was greater than 3x the upper limit of 
normal. ELISA for filamentous actin (FA) was tested and resulted 
positive; however, reflex to smooth muscle antibody (SMA) was 
negative. 
• Without adequate evidence of autoantibodies, treatment was 
withheld until liver histopathology confirmed Type 1 AIH (AIH-1).  
Discussion
In AIH, SMA-T binds to FA. 
• To test for AIH, ELISA for FA is tested first and if positive reflexes to SMA-T 
immunofluorescence 
There a few issues with these tests: 
• Immunofluorescence can be difficult to visualize when titers are low.
• ELISA for FA not been fully standardized leading to varying cutoff values 
depending on assay/laboratory. 
• There is poor correlation between FA ELISA and SMA-T 
immunofluorescence
For our patient, FA levels were significantly elevated yet reflex to smooth muscle 
antibody was negative. 
Conclusion
• Development of reliable testing for FA with improved correlation 
to SMA-T has the potential to provide earlier diagnosis and 
treatment of AIH-1 in patients where SMA titers are negative.
